# Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

> **NCT00096226** · PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 60 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Induction Carboplatin
- **DRUG:** Induction Paclitaxel
- **PROCEDURE:** Resection
- **DRUG:** Consolidation Carboplatin
- **RADIATION:** Radiation Therapy
- **DRUG:** Consolidation Paclitaxel

## Key facts

- **NCT ID:** NCT00096226
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2012-04
- **Final completion:** 2016-05-16
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096226, "Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00096226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*